These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6897018)

  • 1. Absorption kinetics of carbenicillin phenyl sodium and carbenicillin indanyl sodium in man.
    Tanigawara Y; Tamaoka K; Nakagawa T; Uno T
    Chem Pharm Bull (Tokyo); 1982 Jun; 30(6):2174-80. PubMed ID: 6897018
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetic and clinical studies with carfecillin.
    Graber H; Benesch L; Arr M; Magyar T
    Int J Clin Pharmacol Biopharm; 1978 Feb; 16(2):59-62. PubMed ID: 631972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbenicillin prodrugs: kinetics of intestinal absorption competing degradation of the alpha-esters of carbenicillin and prediction of prodrug absorbability from quantitative structure-absorption rate relationship.
    Tsuji A; Miyamoto E; Terasaki T; Yamana T
    J Pharm Sci; 1982 Apr; 71(4):403-6. PubMed ID: 7086645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The availability of carfecillin and its phenol moiety in rat and dog.
    Humphrey MJ; Filer CW; Jeffery DJ; Langley PF; Wadds GA
    Xenobiotica; 1980 Oct; 10(10):771-8. PubMed ID: 7456492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbenicillin prodrugs: stability kinetics of alpha-phenyl and alpha-indanyl esters in aqueous solution.
    Tsuji A; Miyamoto E; Terasaki T; Yamana T
    J Pharm Sci; 1979 Oct; 68(10):1259-63. PubMed ID: 583161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacokinetics of carbenicillin, carfecillin, ticarcillin and BL-P 1654 in dairy cows.
    Nouws JF; Ziv G; Van Ginneken CA; Vree TB
    J Vet Pharmacol Ther; 1984 Mar; 7(1):35-43. PubMed ID: 6323731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The metabolism of carfecillin in rat, dog and man.
    Filer CW; Humphrey MJ; Jeffery DJ; Jones KH; Langley PF
    Xenobiotica; 1980 Oct; 10(10):761-9. PubMed ID: 6256982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacokinetic and clinical research of a new phenyl ester of carbecinillin: carfecillin].
    Sachelariu N; Soranzo ML; Bosio G; Sattinger M; Bramato C; Salassa B
    Minerva Med; 1979 Jul; 70(32):2255-64. PubMed ID: 379704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of carfecillin and carindacillin.
    Modr Z; Dvovácek K; Janků I; Krebs V
    Int J Clin Pharmacol Biopharm; 1977 Feb; 15(2):81-3. PubMed ID: 577917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetics and relative biological availability of karfecillin Spofa (author's transl)].
    Dvorácek K; Jankau I; Krebs V; Modr Z
    Cas Lek Cesk; 1978 Dec; 117(48):1495-9. PubMed ID: 737692
    [No Abstract]   [Full Text] [Related]  

  • 11. Preparation, hydrolysis, and oral absorption of alpha-carboxy esters of carbenicillin.
    Clayton JP; Cole M; Elson SW; Hardy KD; Mizen LW; Sutherland R
    J Med Chem; 1975 Feb; 18(2):172-7. PubMed ID: 804552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carfecillin: antibacterial activity in vitro and in vivo.
    Basker MJ; Comber KR; Sutherland R; Valler GH
    Chemotherapy; 1977; 23(6):424-35. PubMed ID: 21771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absorption and excretion of carbenicillin indanyl sodium in patients with reduced kidney function.
    Nakano H; Sasaki K; Mizoguchi M; Ishibe T; Nihira H
    Chemotherapy; 1977; 23(5):299-308. PubMed ID: 578496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of indanyl carbenicillin by dogs, rats, and humans.
    Hobbs DC
    Antimicrob Agents Chemother; 1972 Oct; 2(4):272-5. PubMed ID: 4670499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacterial prostatitis: treatment with carbenicillin indanyl sodium.
    Mobley DF
    Invest Urol; 1981 Jul; 19(1):31-3. PubMed ID: 7019153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmaceutical aspects of creating an effective drug form of carfecillin].
    Berezovskaia LN; Gavrilova TA; Dedukh NG; Kiseleva TA; Grakovskaia LK
    Antibiot Med Biotekhnol; 1986 Sep; 31(9):684-7. PubMed ID: 3777896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acute toxicity and the cumulative properties of carfecillin].
    Lidovskiĭ MZ; Zel'tser IZ; Berezina EK
    Antibiotiki; 1978 May; 23(5):450-3. PubMed ID: 655692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GI absorption of beta-lactam antibiotics I: kinetic assessment of competing absorption and degradation in GI tract.
    Tsuji A; Miyamoto E; Kagami I; Sakaguchi H; Yamana T
    J Pharm Sci; 1978 Dec; 67(12):1701-4. PubMed ID: 581499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical study of carfecillin in chronic urinary tract infection (author's transl)].
    Hayahara N; Nishijima T; Maeda T; Oyama T; Matsumura T; Nishio S; Funai K; Sasaki S; Nakanishi J; Tsujita M; Kishimoto T; Maekawa M
    Jpn J Antibiot; 1977 Dec; 30(12):993-8. PubMed ID: 599660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of drug decomposition. Part 66. Kinetics of the hydrolysis of carphecillin in aqueous solution.
    Pawełczyk E; Zajac M; Knitter B; Mikołajczak P
    Pol J Pharmacol Pharm; 1981 Oct; 33(3):373-86. PubMed ID: 7322950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.